Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Side Effects Involving the Heart in Women With Breast Cancer Receiving Doxorubicin and Trastuzumab (PACE in BC)

This study is currently recruiting participants. (see Contacts and Locations)
Verified December 2014 by Vanderbilt University
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Douglas Brian Sawyer, Vanderbilt University Identifier:
First received: April 2, 2009
Last updated: December 1, 2014
Last verified: December 2014
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: January 2015 (Final data collection date for primary outcome measure)